•  

    Targeting Cancer, Transforming Lives

    Harnessing the power of the immune system to help extend patients’ lives.

    Learn More
  •  

    Targeting Cancer, Transforming Lives

    Harnessing the power of the immune system to help extend patients’ lives.

    Learn More
  •  

    Targeting Cancer, Transforming Lives

    Harnessing the power of the immune system to help extend patients’ lives.

    Learn More
  •  

    Targeting Cancer, Transforming Lives

    Harnessing the power of the immune system to help extend patients’ lives.

    Learn More
Real-world study of 6,000+ Medicare patients shows adding PROVENGE® (sipuleucel-T) to the mCRPC treatment regimen reduced risk of death by 45%

New data presented at ASCO Genitourinary Cancers Symposium finds adding PROVENGE® to commonly prescribed oral therapies extends median survival by 14.5 months

Visit Newsroom

Who We Are

Our Science

Join Us

Recent News

Stay up to date with the latest discoveries, events, and announcements from Dendreon.

Visit Newsroom